132 related articles for article (PubMed ID: 29702145)
1. Activation of M2 muscarinic acetylcholine receptors by a hybrid agonist enhances cytotoxic effects in GB7 glioblastoma cancer stem cells.
Cristofaro I; Spinello Z; Matera C; Fiore M; Conti L; De Amici M; Dallanoce C; Tata AM
Neurochem Int; 2018 Sep; 118():52-60. PubMed ID: 29702145
[TBL] [Abstract][Full Text] [Related]
2. The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.
Guerriero C; Matera C; Del Bufalo D; De Amici M; Conti L; Dallanoce C; Tata AM
Cells; 2021 Jul; 10(8):. PubMed ID: 34440646
[TBL] [Abstract][Full Text] [Related]
3. The activation of M2 muscarinic receptor inhibits cell growth and survival in human glioblastoma cancer stem cells.
Alessandrini F; Cristofaro I; Di Bari M; Zasso J; Conti L; Tata AM
Int Immunopharmacol; 2015 Nov; 29(1):105-9. PubMed ID: 26033491
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells.
Di Bari M; Tombolillo V; Conte C; Castigli E; Sciaccaluga M; Iorio E; Carpinelli G; Ricordy R; Fiore M; Degrassi F; Tata AM
Neurochem Int; 2015 Nov; 90():261-70. PubMed ID: 26455407
[TBL] [Abstract][Full Text] [Related]
5. M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells.
Ferretti M; Fabbiano C; Di Bari M; Conte C; Castigli E; Sciaccaluga M; Ponti D; Ruggieri P; Raco A; Ricordy R; Calogero A; Tata AM
J Cell Mol Med; 2013 Apr; 17(4):552-66. PubMed ID: 23490231
[TBL] [Abstract][Full Text] [Related]
6. Cross Interaction between M2 Muscarinic Receptor and Notch1/EGFR Pathway in Human Glioblastoma Cancer Stem Cells: Effects on Cell Cycle Progression and Survival.
Cristofaro I; Alessandrini F; Spinello Z; Guerriero C; Fiore M; Caffarelli E; Laneve P; Dini L; Conti L; Tata AM
Cells; 2020 Mar; 9(3):. PubMed ID: 32182759
[TBL] [Abstract][Full Text] [Related]
7. M2 Muscarinic Receptor Stimulation Induces Autophagy in Human Glioblastoma Cancer Stem Cells via mTOR Complex-1 Inhibition.
Guerriero C; Manfredelli M; Matera C; Iuzzolino A; Conti L; Dallanoce C; De Amici M; Trisciuoglio D; Tata AM
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201453
[TBL] [Abstract][Full Text] [Related]
8. M2 muscarinic receptors inhibit cell proliferation in human glioblastoma cell lines.
Ferretti M; Fabbiano C; Di Bari M; Ponti D; Calogero A; Tata AM
Life Sci; 2012 Nov; 91(21-22):1134-7. PubMed ID: 22575825
[TBL] [Abstract][Full Text] [Related]
9. M2 Muscarinic Receptor Activation Impairs Mitotic Progression and Bipolar Mitotic Spindle Formation in Human Glioblastoma Cell Lines.
Di Bari M; Tombolillo V; Alessandrini F; Guerriero C; Fiore M; Asteriti IA; Castigli E; Sciaccaluga M; Guarguaglini G; Degrassi F; Tata AM
Cells; 2021 Jul; 10(7):. PubMed ID: 34359896
[TBL] [Abstract][Full Text] [Related]
10. M2 Receptor Activation Counteracts the Glioblastoma Cancer Stem Cell Response to Hypoxia Condition.
Cristofaro I; Limongi C; Piscopo P; Crestini A; Guerriero C; Fiore M; Conti L; Confaloni A; Tata AM
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131421
[TBL] [Abstract][Full Text] [Related]
11. Mir-34a-5p Mediates Cross-Talk between M2 Muscarinic Receptors and Notch-1/EGFR Pathways in U87MG Glioblastoma Cells: Implication in Cell Proliferation.
Di Bari M; Bevilacqua V; De Jaco A; Laneve P; Piovesana R; Trobiani L; Talora C; Caffarelli E; Tata AM
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857516
[TBL] [Abstract][Full Text] [Related]
12. M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells.
Pacini L; De Falco E; Di Bari M; Coccia A; Siciliano C; Ponti D; Pastore AL; Petrozza V; Carbone A; Tata AM; Calogero A
Cancer Biol Ther; 2014; 15(11):1489-98. PubMed ID: 25482946
[TBL] [Abstract][Full Text] [Related]
13. The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells.
Lucianò AM; Perciballi E; Fiore M; Del Bufalo D; Tata AM
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182656
[TBL] [Abstract][Full Text] [Related]
14. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
[TBL] [Abstract][Full Text] [Related]
15. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
[TBL] [Abstract][Full Text] [Related]
16. Role of Muscarinic Acetylcholine Receptor-2 in the Cerebellar Cortex in Cardiovascular Modulation in Anaesthetized Rats.
Zhang C; Sun T; Zhou P; Zhu Q; Zhang L
Neurochem Res; 2016 Apr; 41(4):804-12. PubMed ID: 26526144
[TBL] [Abstract][Full Text] [Related]
17. Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.
Schrage R; Seemann WK; Klöckner J; Dallanoce C; Racké K; Kostenis E; De Amici M; Holzgrabe U; Mohr K
Br J Pharmacol; 2013 May; 169(2):357-70. PubMed ID: 23062057
[TBL] [Abstract][Full Text] [Related]
18. Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.
Del Bello F; Bonifazi A; Quaglia W; Mazzolari A; Barocelli E; Bertoni S; Matucci R; Nesi M; Piergentili A; Vistoli G
Bioorg Med Chem Lett; 2014 Aug; 24(15):3255-9. PubMed ID: 24980056
[TBL] [Abstract][Full Text] [Related]
19. M2 muscarinic receptor activation inhibits cell proliferation and migration of rat adipose-mesenchymal stem cells.
Piovesana R; Melfi S; Fiore M; Magnaghi V; Tata AM
J Cell Physiol; 2018 Jul; 233(7):5348-5360. PubMed ID: 29227527
[TBL] [Abstract][Full Text] [Related]
20. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
